Market Place
Sourcing Support
Enforcement Report - Week of February 22, 2023
22 Feb 2023 //
FDA
Enforcement Report - Week of January 4, 2023
04 Jan 2023 //
FDA
Takeda’s LIVTENCITY Available for Certain Individuals Ages 12 Years and Older
02 Dec 2021 //
BUSINESSWIRE
Takeda’s LIVTENCITYTM Approved by FDA in CMV; & more
23 Nov 2021 //
BUSINESSWIRE
FDA`s ADAC unanimously backs Takeda`s drug for post-transplant cytomegalovirus
08 Oct 2021 //
ENDPTS
Hikma launches Ganciclovir for Injection, USP
22 Jun 2021 //
PRESS RELEASE
Phase 3 Trial Subgroup Analysis Across SOT Types Supports Efficacy of Maribavir
07 Jun 2021 //
PRESS RELEASE
FDA Action Alert: EyePoint Pharma and Merck
05 Nov 2018 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.